FDA Clears AI Software for Enhanced Lung Nodule Detection on Chest X-Rays
Tailored for incidental findings on chest radiographs, the qXR for Lung Nodule (qXR-LN) software utilizes artificial intelligence (AI) to help detect suspected pulmonary nodules ranging between 6 to 30 mm.
Head CT for Acute Stroke Patients: Study Shows 22 Percent Improvement for 30-Minute Turnaround Times
Modifications to the radiology workflow, including the use of a structured report template, improved adherence for 30-minute turnaround times for acute stroke head CT results from 73.2 percent to 95.6 percent, accordingly to new research.
FDA Grants De Novo Clearance for Ultrasound-Based Liver Tumor Ablation Software
The BioTraceIO software reportedly facilitates visualization of liver tumor ablation procedures based on real-time ultrasound imaging and provides superior post-op estimates of ablation zone volume in comparison to computed tomography.
Optimizing the Radiology Revenue Cycle
January 5th 2024Given the ongoing challenges with receiving appropriate reimbursement in radiology, these authors discuss key principles in the coding and billing process, common challenges and three priorities for bolstering reimbursement revenue in the profession.
Filters and Spectral Shaping: Pillars of Quality in Computed Tomography
January 5th 2024Given the essential role of X-ray filtration in computed tomography (CT) systems, this author discusses key principles and emerging advances with filters and spectral shaping to facilitate quality imaging and optimal radiation dosing.
Hybrid MRI Deep Learning Model Shows Promise in Predicting Tumor Deposits with Rectal Cancer
An emerging deep learning model, which incorporates T2-weighted MRI and clinical data, demonstrated an 83.9 percent AUC and an 85 percent specificity rate for preoperative prediction of tumor deposits in patients with rectal cancer.
What a New Chest CT Study Reveals About Pericardial Effusion and COVID-19
The presence of pericardial effusion on chest computed tomography (CT) was associated with a 56 percent higher 30-day mortality risk in men with COVID-19 but had no impact on the prognosis for women with COVID-19, according to newly published research.
Can a Genetic Model Help Reduce Overuse of Mammography in Women at Low Risk for Breast Cancer?
In a study assessing the use of a genetic risk stratification model to estimate breast cancer risk in over 25,000 women, researchers found that 0.69 percent of women at low genetic risk were diagnosed with breast cancer by the age of 45 and 1.41 percent of this group were diagnosed by the age of 58.